Tag Archive for: Quality Adjusted Life Years
MBTAAnalysis: A look inside the MBTA
0 Comments
/
The MBTA shuttles over a million passengers a day around Greater…
Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?
Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.
New Analysis: ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments
Pioneer Institute today released a new analysis, The QALY and Cancer Treatments: An Ill-Advised Match, that examines the alarming methodological and contextual shortcomings of the Quality Adjusted Life Years (QALY)-based methodology in evaluating new cancer therapies. The Pioneer Institute analysis reveals five specific problems with ICER’s evaluation of cancer treatments and demonstrates the urgent need to prohibit the use of the QALY amid trends in rapid cancer innovations and personalized medicine.
New Report Addresses Distinct Challenges in Utilizing ICER to Assess Value of Rare Disease Treatments
Pioneer Institute Discourages Policymakers & Payers from…
Study Urges Caution Before Adopting ICER Reviews to Determine Cost Effectiveness of Treatments
Review methodology could negatively impact elderly, the disabled,…